Variations and increase in use of statins across Europe: data from administrative databases
BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7436.385 (Published 12 February 2004) Cite this as: BMJ 2004;328:385Data supplement
- Appendix 1: Members of the EURO-MED-STAT Group
Austria—Ingrid Rosian, Sabine Vogler, ÖBIG, Austrian Institute of Health, Vienna
Belgium—Robert vander Stichele, Matus Ferech, Heymans Instituut, University of Gent
Denmark—Lasse Larsen, Bettina Ødegaard, Anne Kirstine Brahm, Lægemiddelstyrelsen Danish Medicines Agency, Brønshøj
Finland—Jaana Martikainen, Tutkimusosasto-Kansaneläkelaitos (Kela), Social Insurance Institution, Helsinki
France—Eric van Ganse, Guihlem Pietri, Unité de Pharmacoépidémiologie, University of Lyon
Germany—Ulrich Schwabe, Pharmacologisches Institut, Ruprecht-Karls-Universität, Heidelberg. Helmut Schröder, Research Institut of the AOK (WIdO)
Greece—Athena Linos, Elena Riza, Department of Hygiene and Epidemiology, School of Medicine, University of Athens
Ireland—Michael Barry, Lesley Tilson, Irish National Centre for Pharmacoeconomics, Dublin
Italy—Pietro Folino, Fabio Palazzo, Giuseppe Stirparo, Institute for Research on Population and Social Policies, National Research Council, Rome. Alessandra Righi, ISTAT-Istituto Nazionale di Statistica (National Institute for Statistics), Rome. Mario Bruzzone, Emma Puca, Comitato Interministeriale per la Programmazione Economica-Farmaci, Ministero dell’ Economia e delle Finanze (Ministry of Economics), Rome. Nello Martini, Antonio Addis, Direzione Generale per la Valutazione dei Medicinali e la Farmacovigilanza, Ministero della Salute (Ministry of Health), Rome
Netherlands—Petra Jansen, Directie Genees, en Hulmiddlenvoorziening, Ministerie van Volksgezondheid, Wlzijn en Sport (Ministry of Health, Welfare and Sport), The Hague
Norway—Marit Rønning, Irene Litleskare, WHO Collaborating Centre for Drug Statistic Methodology, Oslo
Portugal—Antonio Faria Vaz, Angela Antonio, INFARMED-Instituto Nacional da Farmacia e do Medicamento (National Institute of Pharmacy), Lisbon
Spain—Alfonso Carvajal, Maria Sainz, Centro Regional de Farmacovigilancia de Castilla y Leon, IFE-Instituto de Farmacoepidemiología, University of Valladolid
Sweden—Karolina Antonov, Anders Carlsten, Apoteket AB, National Corporation of Swedish Pharmacies, Stockolm
United Kingdom—Tom Walley, Prescribing Research Centre, Department of Pharmacology and Therapeutics, University of Liverpool
WHO-Europe—Kees de Joncheere, Regional Adviser for Pharmaceuticals and Technology, WHO, Regional Office for Europe, Copenhagen
Web appendix 2: Information sources for state expenditure on and use of statins
Austria—Hauptverband der Österreichischen Sozialversicherungsträger/PEGASUS (Federation of Austrian Social Insurance Institutions)
Belgium—Farmanet (RijksInstituut voor Ziekte en InvaliditeitsVerzekering/Institut National d’Assurance Invalidité) (National Institute for Health and Disability Insurance)
Denmark—Lægemiddelstyrelsen (Danish Medicines Agency)
Finland—Lääkemyyntirekisteri, Lääkelaitos (drug sales register owned by the National Agency for Medicines)
France—Caisse Nationale d’Assurance Maladie (CNAM) base de données Médicam (National Health Insurance—database Medicam)
Germany—Database of the German Drug Index, Research Institute of the AOK (WIdO)
Ireland—Reimbursement files from the General Medical Services Payments Board
Italy—Ministero della Salute-Osservatorio Nazionale sull’Impiego dei Medicinali (OsMed) (Ministry of Health-Observatory on Utilisation of Medicines)
Netherlands—College voor Zorgverzekeringen, Geneesmiddelen Informatie Project Amstelveen/Stichting Farmaceutische Kengetallen Den Haag (Health Care Insurance Board, Pharmaceutical Products Information Project Amstelveen/Foundation for Pharmaceutical Statistics, The Hague)
Norway—Norwegian Institute of Public Health (data based on total sales from all Norwegian wholesalers)
Portugal—INFARMED-National Institute of Pharmacy
Spain—Agencia Española del Medicamento, Especialidades y consumo de medicamentos (database ECOM) (Ministry of Health, Spanish Medicines Agency)
Sweden—Apoteket, National Corporation of Swedish Pharmacies
United Kingdom—Prescription Pricing Authority (PPA)
Related articles
- This Week In The BMJ Published: 12 February 2004; BMJ 328 doi:10.1136/bmj.328.7436.0-a
- Correction Published: 05 August 2004; BMJ 329 doi:10.1136/bmj.329.7461.323-a
See more
- Dengue: Argentinians turn to homemade repellent amid surge in casesBMJ April 17, 2024, 385 q885; DOI: https://doi.org/10.1136/bmj.q885
- Devolved powers for Greater Manchester led to some health improvements, study showsBMJ March 28, 2024, 384 q767; DOI: https://doi.org/10.1136/bmj.q767
- Long waits in child mental health are a “ticking time bomb” regulator warnsBMJ March 22, 2024, 384 q724; DOI: https://doi.org/10.1136/bmj.q724
- Doctors report big rise in patients with illness because of socioeconomic factorsBMJ March 01, 2024, 384 q538; DOI: https://doi.org/10.1136/bmj.q538
- Diphtheria: WHO publishes first ever guidance following outbreaksBMJ February 14, 2024, 384 q407; DOI: https://doi.org/10.1136/bmj.q407
Cited by...
- Temporal Changes in Cardiac Troponin I Are Associated with Risk of Cardiovascular Events in the General Population: The Nord-Trondelag Health Study
- Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease
- Monitoring the use of lipid-lowering medication among persons with newly diagnosed diabetes: a nationwide register-based study
- Cardiovascular disease beyond the QOF
- Improved Long-Term Survival After Abdominal Aortic Aneurysm Repair
- Statins and the Risk of Colorectal Cancer: A Meta-Analysis of 18 Studies Involving More Than 1.5 Million Patients
- Do Statins Reduce Blood Pressure?: A Meta-Analysis of Randomized, Controlled Trials
- Statin Use and Risk of Lymphoid Neoplasms: Results from the European Case-Control Study EPILYMPH.
- Opportunities, Challenges, and Lessons of International Research in Practice-Based Research Networks: The Case of an International Study of Acute Otitis Media
- Variations and increase in use of statins across Europe: data from administrative databases